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Glucagon release by pancreatic a cells is stimulated by low glucose through unclear mechanisms. In this is-
sue of Cell Metabolism, Cabrera et al. (2008) show that glutamate released from a cells acts on glutamate re-
ceptors in a positive autocrine fashion that drives glucagon secretion during small physiological fluctuations
of blood glucose.Pancreatic islet cells (a, b, and d cells) ex-
quisitely regulate their secretion of the
hormones that collectively maintain glu-
cose homeostasis through actions on
peripheral tissues (liver, muscle, adipose
tissue). Insulin released from b cells in-
creases glucose uptake by peripheral tis-
sues, while glucagon released from a cells
mobilizes glucose from peripheral tissues
into the circulation; somatostatin released
from d cells inhibits both a and b cell
secretion. Whereas blood glucose level
is a primary signal regulating islet secre-
tions, the islet is profoundly influenced
by a complex network of paracrine and
autocrine factors whose precise nature
remain unclear. In diabetes, this network
is disrupted: in this ‘‘glucose-blind’’ state,
glucose loses some of its ability to control
islet secretion, in particular glucagon
release from a cells.
While glucagon secretion from the a cell
has been closely examined (for review, see
Gromada et al., 2007), even the supposi-
tion that low glucose stimulates a cells to
secrete glucagon while high glucose
causes cessation of glucagon release re-
mains in debate. Themechanism by which
high glucose suppresses a cell secretion
has been attributed not only to somato-
statin but also to additional inhibitory para-
crine factors secreted by the adjacent
b cells (insulin, Zn2+, GABA) in response
to high glucose (Figure 1A). These para-
crine factors inhibit a cell glucagon secre-
tionbyvariously causingmembranehyper-
polarization to dampen a cell excitability.
Somatostatin hyperpolarizes a cells by
activating a low-conductance K+ channel
coupled to inhibitory G proteins (Gromada
et al., 2007), while GABA hyperpolarizes
a cells by activating Cl influx (Wendt474 Cell Metabolism 7, June 2008 ª2008 Elset al., 2004). Both insulin (Leung et al.,
2006) and Zn2+ (Franklin et al., 2005) cause
membrane hyperpolarization in a cells by
activating KATP channels.
Autocrine mechanisms can also regu-
late a cell function, both positively and
negatively (Figure 1A). The main product
of the a cell, glucagon, seems to be able
to promote further glucagon release
(Ma et al., 2005). Glutamate is cosecreted
with glucagon, and its role as an autocrine
factor has been controversial. In rats, glu-
tamate was initially thought to stimulate
glucagon secretion by activating a cell
ionotropic glutamate receptors (Bertrand
et al., 1993), but a subsequent study
showed that glutamate, acting on a cell
metabotropic glutamate receptor type 4
(mGluR4), inhibits glucagon secretion
(Uehara et al., 2004).
In this issue of Cell Metabolism, Cab-
rera et al. (2008) provide evidence that
glutamate can act as a positive autocrine
signal for a cell glucagon release in pri-
mates (human and monkey) and mice.
Employing a variety of elegant experimen-
tal approaches, they show that glutamate
is indeed secreted by a cells in response
to low glucose concentration. Moreover,
the secreted glutamate acts in a positive
autocrine manner in vitro and in vivo
through a cell ionotropic glutamate recep-
tors (iGluRs). In human islets, glucagon
release was stimulated by glutamate or
by iGluR-specific agonists. Metabotropic
glutamate receptors (mGluRs) did not ap-
pear to play a role, since glucagon release
was not influenced by either mGluR ago-
nists or antagonists. Single-cell RT-PCR
detected iGluR transcripts of AMPA/
kainate subtypes in human and monkey
a cells but little or no transcripts ofevier Inc.mGluR4 or mGluR5. Indeed, glutamate-
stimulated glucagon release was compa-
rable in wild-type and mGluR4 knockout
mice. The authors build a convincing
argument that the mGluR-mediated auto-
crine inhibition of a cell glucagon secre-
tion by glutamate observed in rats (Ue-
hara et al., 2004) is minimal or absent in
humans (andmonkeys andmice): in these
latter species, the positive autocrine ac-
tion on a cell iGluRs seems to dominate
and promote glucagon release. Species
differences in glutamate actions are thus
explained by the distinct subtypes of glu-
tamate receptors on their a cells.
How does glutamate stimulate glucagon
release? The model in Figure 1B summa-
rizes the authors’ data. Upon low-glu-
cose-stimulated glucagon granule exocy-
totic fusion, glutamate is cosecreted with
glucagon. Glutamate acts on the a cell
iGluRs of the AMPA and kainate subtypes,
which are Na+-permeable nonselective
cation channels (with limited Ca2+ perme-
ability) (Wollmuth and Sobolevsky, 2004).
Influx of Na+ and Ca2+ following iGluR acti-
vation leads to membrane depolarization,
with consequent opening of voltage-gated
Ca2+ channels and Ca2+-driven exocytosis
to release more glucagon (and glutamate).
Islet a and b cells seem to packagemul-
tiple secretory products in dense-core
granules. In b cells, insulin granules also
contain ATP, Zn2+, and even GABA,
smaller products that are differentially
released depending on the size of the
exocytotic fusion pore opening (MacDon-
ald and Rorsman, 2007). Insulin granule
exocytotic fusion does not always pro-
ceed by complete vesicle collapse that
empties all the cargo; many (or most) of
the secretory granules undergo transient
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Previewspartial fusion with incomplete fusion pore
opening (‘‘kiss and run’’). The precise
mechanisms for the regulation of fusion
pore opening remain unclear. Nonethe-
less, this raises the possibility that gluta-
mate (which is smaller than glucagon)
and glucagon could be similarly differen-
tially released from a cell dense-core
granules to confer an even more precise
autocrine regulation. Since the distorted
biphasic insulin secretory response of
diabetes is known to involve altered dock-
ing and fusion of insulin granules (Ohara-
Imaizumi et al., 2004), it seems plausible
that diabetes could also distort the fusion
pore opening dynamics of both b and
a cells, thereby perturbing paracrine and
autocrine control. Cabrera et al. (2008)
offer an alternative explanation: the
reduced b cell mass of diabetes leads
to chronic release of glutamate, which
downregulates a cell iGluRs and reduces
the positive feedback loop for glucagon
release. This reduced positive feedback
may require a lower glucose concentra-
tion to stimulate glucagon secretion,
partly explaining a cell ‘‘glucose blind-ness.’’ Further work will be needed to
dissect these possibilities.
This demonstration by Cabrera et al.
(2008) of a cell positive autocrine regula-
tion by glutamate release and iGluR acti-
vation provides an interesting mechanism
by which the a cell is able to ‘‘kick’’ itself
just hard enough to regulate glucagon
secretion over the narrow range of low
blood glucose fluctuation. In diabetes,
the pancreatic islet’s Three Musketeers
(a, b, and d cells), the ‘‘guardians’’ of glu-
cose homeostasis, cease to get along; in-
stead, they interact with each other like
circus clowns tripping on themselves and
each other due to excessive glucose
fluctuations or altered autocrine or para-
crine mechanisms and are thus unable
to maintain normoglycemic control. Fur-
ther work to refine this hypothesis should
provide more new and important insights.
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Trends Neurosci. 27, 321–328.Figure 1. Paracrine and Autocrine Regulation of a Cell Secretion
(A) a cell secretion is under negative paracrine control by b and d cells. Glucagon released by a cells provides a positive autocrine signal, while glutamate may
exert either a negative or positive autocrine effect depending on the receptor subtype on which glutamate acts (see text).
(B) In a cells, activation of ionotropic glutamate receptors (iGluRs) of the AMPA and kainate subtypes by glutamate results in Na+ and Ca2+ influx, subsequently
leading to membrane depolarization, opening of voltage-gated Ca2+ channels, and Ca2+-triggered secretory granule exocytosis. Note that for the AMPA and
kainate receptor subtypes, Na+ permeability is considerably higher than Ca2+ permeability.
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